BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Chinese Patent Office
Cantor Fitzgerald
Colorcon
Cipla
Boehringer Ingelheim
Fuji
Farmers Insurance
Novartis

Generated: January 16, 2018

DrugPatentWatch Database Preview

Elite Labs Company Profile

« Back to Dashboard

What is the competitive landscape for ELITE LABS, and what generic and branded alternatives to ELITE LABS drugs are available?

ELITE LABS has fourteen approved drugs.



Summary for Elite Labs
US Patents:0
Tradenames:9
Ingredients:9
NDAs:14

Drugs and US Patents for Elite Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elite Labs Inc DANTROLENE SODIUM dantrolene sodium CAPSULE;ORAL 076686-002 Oct 24, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 040448-001 Jan 22, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-001 Apr 24, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-003 Aug 2, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET;ORAL 076723-001 Oct 18, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076868-001 Aug 4, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 200272-001 Jan 31, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 040228-001 Jun 19, 1997 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 202248-002 Sep 28, 2012 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elite Labs Inc DANTROLENE SODIUM dantrolene sodium CAPSULE;ORAL 076686-001 Oct 24, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Healthtrust
Fish and Richardson
Harvard Business School
Farmers Insurance
Cipla
US Department of Justice
Covington
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot